Germline mutations in PALB2 in African-American breast cancer cases
- 27 November 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 126 (1), 227-230
- https://doi.org/10.1007/s10549-010-1271-7
Abstract
Breast cancer incidence is lower in African Americans than in Caucasian Americans. However, African-American women have higher breast cancer mortality rates and tend to be diagnosed with earlier-onset disease. Identifying factors correlated to the racial/ethnic variation in the epidemiology of breast cancer may provide better understanding of the more aggressive disease at diagnosis. Truncating germline mutations in PALB2 have been identified in approximately 1% of early-onset and/or familial breast cancer cases. To date, PALB2 mutation testing has not been performed in African-American breast cancer cases. We screened for germline mutations in PALB2 in 139 African-American breast cases by denaturing high-performance liquid chromatography and direct sequencing. Twelve variants were identified in these cases and none caused truncation of the protein. Three missense variants, including two rare variants (P8L and T300I) and one common variant (P210L), were predicted to be pathogenic, and were located in a coiled-coil domain of PALB2 required for RAD51- and BRCA1-binding. We investigated and found no significant association between the P210L variant and breast cancer risk in a small case–control study of African-American women. This study adds to the literature that PALB2 mutations, although rare, appear to play a role in breast cancer in all populations investigated to date.Keywords
This publication has 23 references indexed in Scilit:
- PALB2: a novel inactivating mutation in a Italian breast cancer familyFamilial Cancer, 2010
- A recurrent mutation in PALB2 in Finnish cancer familiesNature, 2007
- PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility geneNature Genetics, 2006
- Models of genetic susceptibility to breast cancerOncogene, 2006
- Prevalence and Predictors of BRCA1 and BRCA2 Mutations in a Population-Based Study of Breast Cancer in White and Black American Women Ages 35 to 64 YearsCancer Research, 2006
- Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2Molecular Cell, 2006
- PMUT: a web-based tool for the annotation of pathological mutations on proteinsBioinformatics, 2005
- Breast Cancer in African-American WomenThe Oncologist, 2005
- Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancerHuman Genetics, 2000
- Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer.1997